TargetP2Y purinoceptor 14(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 0.430nMAssay Description:Antagonist activity at human P2Y14 expressed in CHO cells assessed as inhibition of forskolin-induced increase of cAMP accumulation incubated for 15 ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens)
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 330nMAssay Description:Inhibition of dopamine D3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 390nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 650nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 710nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 860nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens)
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of dopamine D3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1B) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of dopamine D5 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1B) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of dopamine D5 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1B) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of dopamine D5 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1B) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of dopamine D5 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of muscarinic M1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of SERT receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetAlpha-2B adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic beta 3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic beta 3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic beta 3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic beta 3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetBeta-3 adrenergic receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of adrenergic beta 3 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT2C receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1D(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT1D receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1D(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT1D receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1D(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT1D receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of KOR (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1D(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT1D receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1D(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: >1.00E+3nMAssay Description:Inhibition of serotonin 5HT1D receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.10E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.20E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.20E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Inhibition of sigma 1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetTranslocator protein(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of TSPO receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma non-opioid intracellular receptor 1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Inhibition of sigma 1 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetSigma intracellular receptor 2(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Inhibition of sigma 2 receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair
TargetTranslocator protein(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
National Institute Of Diabetes And Digestive And Kidney Diseases
Curated by ChEMBL
Affinity DataKi: 1.80E+3nMAssay Description:Inhibition of TSPO receptor (unknown origin) assessed as binding constantMore data for this Ligand-Target Pair